Free Trial
NASDAQ:MTSR

Metsera (MTSR) Stock Price, News & Analysis

Metsera logo
$40.47 +0.82 (+2.07%)
As of 07/25/2025 04:00 PM Eastern

About Metsera Stock (NASDAQ:MTSR)

Key Stats

Today's Range
$37.29
$40.95
50-Day Range
$25.38
$44.30
52-Week Range
$12.30
$47.40
Volume
1.02 million shs
Average Volume
752,554 shs
Market Capitalization
$4.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Buy

Company Overview

Receive MTSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metsera and its competitors with MarketBeat's FREE daily newsletter.

MTSR Stock News Headlines

Metsera Inc.'s (NASDAQ:MTSR) Lock-Up Period To Expire on July 30th
Metsera (NASDAQ:MTSR) Reaches New 52-Week High - Should You Buy?
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

MTSR Stock Analysis - Frequently Asked Questions

Metsera's stock was trading at $29.50 at the start of the year. Since then, MTSR shares have increased by 37.2% and is now trading at $40.47.

Metsera Inc. (NASDAQ:MTSR) posted its quarterly earnings data on Monday, May, 12th. The company reported ($1.03) EPS for the quarter.

Metsera (MTSR) raised $275 million in an initial public offering (IPO) on Friday, January 31st 2025. The company issued 15,277,778 shares at a price of $18.00 per share.

Metsera's lock-up period expires on Wednesday, July 30th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. After the expiration of Metsera's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Top institutional investors of Metsera include Exchange Traded Concepts LLC (0.04%) and KLP Kapitalforvaltning AS.

Shares of MTSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTSR
Previous Symbol
NASDAQ:MTSR
CIK
2040807
Web
N/A
Fax
N/A
Employees
81
Year Founded
N/A

Price Target and Rating

High Price Target
$65.00
Low Price Target
$38.00
Potential Upside/Downside
+35.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.55
Quick Ratio
6.55

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.46) per share
Price / Book
-16.45

Miscellaneous

Outstanding Shares
105,060,000
Free Float
N/A
Market Cap
$4.25 billion
Optionable
N/A
Beta
N/A

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:MTSR) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners